ARAC Healthcare

Since establishment in 1996 as an authorized distributor for Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), ARAC powerfully penetrated the Kingdom's market of pharmaceuticals and relevant healthcare products distribution. Today, many pharmaceutical and healthcare products dispensed to the kingdom patients travel through the efficient nationwide network of ARAC, thanks to the state of the art IT system that provides better customized solutions to client's needs. Recently, our capabilities extended beyond the logistics support, by assisting global pharmaceutical companies’ business activities in the region with sales, and marketing, etc.

PNP Pharmaceuticals Inc.

PNP Pharmaceuticals is a unique contract manufacturer of nutraceutical and pharmaceutical products. We are a highly accredited company with an emphasis on quality and service, on a level which sets us apart from our competitor. From the minute, you enter our facility or speak to us via telephone our commitment to excellence is clearly evident. We are simply different, from our unrivaled service, knowledge and expertise, and overall quality, to our professional yet friendly demeanor. We are a young, energetic, and exciting company that strives to be the best at what we do; manufacture quality products.

kremoint pharma private limited

We KREMOINT PHARMA PVT LTD is fast growing pharmaceutical & Consumer wellness company engaged in developing, manufacturing, marketing & exporting high quality pharmaceutical dosage forms like Creams, Lotions, Gel, Tablets, Suppositories, Lozenges, Injectables, Syrups, Cosmetic products for the local market across the world. We have niche expertise in the development and manufacturing of suppositories and pessaries and Derma Topical products, which has been our core business for over three decades. Our creams & Ointments manufacturing facility is WHO-GMP certified, US FDA, HEATH CANADA approved for OTC range, registered in more than 25 countries world wide. Secondly, we have 3 state-of-the-art facility those are highly dedicated for manufacturing of Suppositories & Pessaries with US FDA, WHO-GMP, EU-GMP, TGA, ISO 14001:2015 compliant. Our new facility for manufacturing of Tablets, Capsules & Sachets is also WHO-GMP Approved with plant compliant to US FDA & European Approved standards. We also have a facility for manufacturing of API’s. Utilizing over more than 28 years of experience, we have created a unique team to cater our customer needs. We have our own in-house quality control, quality assurance and research and development facilities for continuous innovation and development. We follow the strong guideline of quality. Thus our state of art manufacturing facility is designed in a way that it can meet major international guidelines and certifications.

Costello Medical

At Costello Medical, we enjoy building lasting partnerships in the healthcare sector by providing exceptional service. Our vision is to be a leading global partner consistently striving for meaningful and outstanding contributions that improve people’s health and lives. Our experts support the healthcare sector in the analysis, interpretation, and communication of clinical and health economic data; our service offerings include evidence development, statistics, health economics, HTA, real-world evidence, market access, medical affairs, publications, and design. We are one of the most established independent agencies delivering medical communications and health economic services. We have grown organically since foundation in 2008 to a team of over 350 based in Cambridge, London, Manchester and Bristol in the UK and internationally in Singapore, China and the US. Our talented team has experience with a variety of leading pharmaceutical and device companies across an extensive range of therapy areas and geographies, including Europe, Asia Pacific, and North America. We are proud to have achieved a 3-star accreditation with Best Companies™ for a sixth consecutive year, and have achieved B Corp certification, showing that we meet the highest standards of verified social and environmental performance.

MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Please visit mannkindcorp.com to learn more.